Talk:Sézary disease
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Sézary disease.
|
Broken references
editCitation [4] leads to a broken link/unregistered domain--could also stand for a more recent reference ("no known causes of Sezary's") as this one is from 2008 anyway --Actually, many of the references cite sezary.com, which is no longer a registered domain. Chengjason7 (talk) 05:21, 9 November 2017 (UTC)
Treatment section?
editUnsure if I'm reading this wrong (little knowledge of the subject), but the abstract of the cited article [11] for the first sentence of "Treatment" along with the linked articles for Vorinostat and Romidepsin don't seem to indicate that the two drugs are second-line--in fact, the article's abstract seems to indicate that HDAC inhibitors/HDI are first-line, with chemo etc being second options.Chengjason7 (talk) 05:26, 9 November 2017 (UTC)
If this is untrue, should the first-line options be also listed? The wording in the treatment section seems unclear/disorganized in general, with the last sentence being a standalone direct quote from the oncology journal the sentence cites [18] Chengjason7 (talk) 05:26, 9 November 2017 (UTC)
rewording direct quotations from citations
editlots of sentences here are direct quotes from the references they cite, with [2] being the main source--this includes the first sentence of the Epidemiology section, which is also about MF and not totally relevant to the epidemiology of Sezary. Removed that sentenceChengjason7 (talk) 05:30, 9 November 2017 (UTC)